Science Will Win

Pfizer

Science Will Win is a podcast that takes listeners under the microscope of some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating science, policy challenges, and potential to transform patients’ lives for the better. This podcast is powered by Pfizer.

  • 18 April 2024, 10:00 am

    Live from SXSW - Moonshot Culture: Innovating to Outdo Yesterday

    Play
    49 minutes 30 seconds
  • 18 April 2024, 9:55 am

    Live from SXSW - Scientific Storytelling: The Audio Advantage

    Play
    52 minutes 8 seconds
  • 18 April 2024, 9:50 am

    Live from SXSW - The Future of Cancer

    Play
    43 minutes 58 seconds
  • 5 December 2023, 11:00 am

    Part 4 – Using AI to Get One Step Ahead of Antibiotic Resistance

    Play
    31 minutes 38 seconds
  • 28 November 2023, 11:00 am

    Part 3 – AI in the Lab: Accelerating Antibiotic Discovery

    Play
    26 minutes 51 seconds
  • 21 November 2023, 11:00 am

    Part 2 – The Power of Data and Artificial Intelligence

    Play
    30 minutes 11 seconds
  • 15 November 2023, 11:00 am

    Part 1 – The Battle Against Antibiotic Resistance

    Play
    27 minutes 49 seconds
  • 7 November 2023, 11:00 am

    Coming Soon – Science Will Win, Season 3

    Play
    4 minutes 5 seconds
  • 27 October 2022, 10:00 am

    Part 1: Breast Cancer: The Science, The Challenges, The Solutions

    Play
    30 minutes 57 seconds
  • 27 October 2022, 10:00 am

    Part 2: Clinical Trials: Bringing Research to Life

    Play
    29 minutes 23 seconds
  • 13 October 2022, 10:00 am

    Coming Soon – Science Will Win, Season 2

    Play
    9 minutes 17 seconds
  • More Episodes? Get the App
© MoonFM 2024. All rights reserved.